Metabolic Impacts of Ren-Nu: A Dietary Program for Polycystic Kidney Disease

Part of paid clinical trials in Cleveland, Ohio.

Sponsor
Richard Fatica
Study ID
NCT07454174
Status
Recruiting
Apply to this trial

Conditions

  • Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Ren-Nu and KetoCitra — DIETARY_SUPPLEMENT
    This is a structured, nutritionist monitored program supplemented with a nutritional food product, while monitoring metabolic parameters

Study Details

This is a 16 week pilot study of the impact of a nutritionist led ketogenic diet (Ren-Nu) supplemented with the medical food KetoCitra on autosomal dominant polycystic kidney disease.

Key Dates

Start date
Feb 25, 2026
Status verified
Mar 2026
Primary completion
Feb 28, 2027
Completion
Feb 29, 2028

Study Design

Enrollment
20 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT

Arms

  • Experimental: Pilot study on ketogenic diet Ren-Nu and KetoCitra supplement on ADPKD
    Nutritional counseling and instruction in a ketogenic diet and nutritional food supplement

Primary Outcome Measure

Change in Serum Renal Function [ Time Frame: Visit 2 (Day 0) before Ren-Nu and Visit 3 (Day 120) after Ren-Nu ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Cleveland ClinicClevelandOhio44195
Chloe Booth
[email protected]
216-444-5053
Richard Fatica, MD
[email protected]
216-445-9953
Richard Fatica, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Cleveland, OH

By research site
Cleveland Clinic· Cleveland, OH

Related Studies